Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV/AIDS at the Kitwe Central Hospital, blood bank
Background: Human Parvovirus (B19V) is a small, single-stranded, non-enveloped DNA virus which is pathogenic to humans causing a wide array of clinical complications which include erythema infectiosum, aplastic crisis and hydrops foetalis. It is generally harmless in healthy individuals but may be l...
Gespeichert in:
Veröffentlicht in: | African health sciences 2018-09, Vol.18 (3), p.496-502 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Human Parvovirus (B19V) is a small, single-stranded,
non-enveloped DNA virus which is pathogenic to humans causing a wide
array of clinical complications which include erythema infectiosum,
aplastic crisis and hydrops foetalis. It is generally harmless in
healthy individuals but may be life threatening in immunocompromised
individuals such as patients with sickle cell disease, cancer, HIV and
pregnant women. It has been shown to be transmissible by blood
transfusion but donor screening for the virus is not yet mandatory in
most sub-Saharan African countries including Zambia. Materials and
methods: This was a cross-sectional study undertaken at the Kitwe
Central Hospital, blood bank and Tropical Diseases Research Centre at
Ndola Central Hospital. A total of 192 blood samples were screened for
Ig M antibodies against parvovirus B19 by ELISA. Objectives: The
general objective of the study was to determine the seroprevalence of
parvovirus B19 infections among healthy blood donors at the Kitwe
Central Hospital blood bank. Specific Objectives were to detect
parvovirus B19 Ig M antibodies in donor blood using serology and to
analyse the age and sex distribution of parvovirus among blood donors.
Results: The prevalence of parvovirus B19 Ig M in this study was 15.6%.
The majority of the positive cases were in the age group 15-22 years
(17.8%) but there was no statistical significance between occurrence of
parvovirus and age ( p value=0.703). Prevalence in males was higher
than in females that is 16.4% and 13.8%, respectively. The relationship
between gender and parvovirus B19 occurrence was however not
significant either (p value=0.516) Conclusion: This study showed a
15.6% prevalence rate of acute Parvovirus B19 infections in blood
donors at the Kitwe Central Hospital, blood bank. Studies with larger
sample sizes are needed to validate these results. |
---|---|
ISSN: | 1680-6905 1729-0503 1680-6905 |
DOI: | 10.4314/ahs.v18i3.5 |